ORTEXORTEX News
Tracking CME? Get live short interest, options flow, and signals on ORTEX.Sign up free →
CM
ConfluenceCME

CME Options Turn Defensive as Bears Rebuild

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 11 Sept 2026, 10:17

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Why this matters: Three separate signals on CME Group are moving in the same direction this week. Options traders are buying more puts. Short sellers are rebuilding positions. And a Deutsche Bank downgrade from late August still hangs over the stock. The convergence is worth watching with October earnings six weeks out.

Put/Call Ratio Hits a Z-Score Extreme

The standout signal is in options. CME's put/call ratio reached 1.20 on September 10. That is the highest reading in weeks. Against a 20-day mean of 1.01 and a standard deviation of 0.064, the z-score lands at 2.89. That is a statistically unusual lean toward protection. Options traders are not neutral. They are buying puts at a pace well outside the recent norm.

Short Sellers Return After a Quiet Spell

The previous ORTEX note from September 2 captured a different story. Short interest was at 1.43% of free float and falling fast. Bears were leaving voluntarily. That has reversed sharply. SI has climbed 21% over the past week to 1.73% of free float as of September 9. The one-day jump alone was 14%. That is a meaningful rebuild — the sharpest weekly increase since late August — though the absolute level remains low.

The borrow market is not strained. Availability sits at 4,025% — roughly 40 shares still available for every one already borrowed. Cost to borrow fell 53% over the week to 0.42%. Bears can build positions cheaply and easily.

Analyst Backdrop Remains a Headwind

Deutsche Bank downgraded CME to Hold from Buy on August 19, cutting the target from $286 to $270. The stock is currently at $274.07. That puts it trading above the Deutsche Bank target with a Hold rating. TD Cowen reiterated Buy with a $292 target on September 3, but the consensus sits at hold overall: three buys, five holds. JP Morgan and B of A Securities both carry negative ratings. Morgan Stanley is the bull outlier with a $330 target.

The ORTEX short score has ticked up from 29.4 to 31.3 over the past ten days. It is not extreme, but the direction is clear.

Data Summary

  • Short interest: 1.73% of free float, +21.1% week-on-week
  • Put/call ratio: 1.20, z-score 2.89 vs. 20-day mean of 1.01
  • Cost to borrow: 0.42%, down 52.6% on the week
  • Availability: 4,025% — loose, no borrow constraint
  • Short score: 31.3, up from 29.4 ten days ago
  • Next earnings: October 21
  • Analyst consensus: Hold; mean price target $283, vs. $274 close
  • Stock: -2.8% on the week, peers also broadly lower

Stocks in this article

See the live data behind this article on ORTEX.

Open CME on ORTEX →

How this article was generated

Generated
11 Sept 2026, 10:18
Data as of
11 Sept 2026, 10:17
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.